Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lallemand Finalizes Acquisition of Evolva, Swiss Biotech Company - Nutraceuticals World

What are you searching for?

Sign in
Market Updates, Products & Ingredients

Lallemand Finalizes Acquisition of Evolva, Swiss Biotech Company

Evolva’s proprietary precision fermentation tech offers a strategic fit with Lallemand’s yeast-based technology.

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Lallemand Inc, a global biotech company headquartered in Canada, has closed the acquisition of Swiss biotechnology business Evolva AG from Evolva Holding AG.

The transaction was originally announced to the Swiss Stock Exchange on Nov. 21, 2023 and was approved by Evolva Holding shareholders at a meeting on Dec. 21, 2023. Lallemand acquired Evolva through its subsidiary, Danstar Ferment AG.

Headquartered in Reinach, Basel (Switzerland) Evolva is focused on the research, development, and commercialization of natural ingredients derived from yeast for applications across the flavors and fragrances, health Ingredients, cosmetics, and health protection industries.

“Evolva offers us a strong strategic fit with our yeast-based technology platform,” said President of Lallemand Bio-Ingredients Lars Asferg. “Evolva’s proprietary precision fermentation technology and R&D capabilities presents an ideal platform from which to expand our product offering mainly within health ingredients like Veri-te resveratrol and flavor & fragrance aroma components like Valencene and natural Nootkatone.”

“We look forward to welcoming the (48) Evolva employees into our Lallemand family and continuing to work with suppliers, existing, and new customers in bringing sustainable, yeast-based ingredients to markets globally via Lallemand’s extensive commercial and operational network.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics